What is the current Price Target for the Forte Biosciences Inc stock?

The average Forte Biosciences Inc target price is $60.18. This is 391.27% higher than the current stock price. The highest price target is 422.86%, the lowest is 369.96%. 4 Analysts have issued a price target Forte Biosciences Inc 2026 .

How high will the Forte Biosciences Inc stock rise?

No reliable answer can be given as to how high the Forte Biosciences Inc stock will rise. The performance of stocks, including the Forte Biosciences Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Forte Biosciences Inc stock today?

The performance of Forte Biosciences Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Forte Biosciences Inc stock fall?

The decline in Forte Biosciences Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Forte Biosciences Inc Forecast, price target & analysts

$12.25

7.36% yesterday

Nasdaq, Jun 27, 10:00 pm CET

ISIN

US34962G1094

Symbol

FBRX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Forte Biosciences Inc Target price 2025 - Analyst rating & recommendation

Forte Biosciences Inc Classifications & Recommendation:

Buy

89%

Hold

11%

Forte Biosciences Inc Price Target

Target Price	$60.18
Price	$12.25
Potential	391.27% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Forte Biosciences Inc 2026 . The average Forte Biosciences Inc target price is $60.18. This is 391.27% register free of charge higher than the current stock price. The highest price target is $64.05 422.86% register free of charge , the lowest is $57.57 369.96% register free of charge .
	A rating was issued by 9 analysts: 8 Analysts recommend Forte Biosciences Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Forte Biosciences Inc stock has an average upside potential 2026 of 391.27% register free of charge . Most analysts recommend the Forte Biosciences Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-12.00	-3.74
	51.22%	68.83%
P/E		negative

5 Analysts have issued a Forte Biosciences Inc forecast for earnings per share. The average Forte Biosciences Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-12.00	51.22%
2025	$-3.74 68.83% Unlock
2026	$-2.80 25.13% Unlock
2027	$-3.13 11.79% Unlock
2028	$-2.18 30.35% Unlock
2029	$-4.93 126.15% Unlock
2030	$-3.61 26.77% Unlock

Current	-3.17	351.88%
2025	-3.28 3.62% Unlock
2026	-4.38 33.54% Unlock
2027	-3.91 10.73% Unlock
2028	-5.61 43.48% Unlock
2029	-2.49 55.61% Unlock
2030	-3.39 36.14% Unlock

Forte Biosciences Inc...

Current Forte Biosciences Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Chardan Capital	Locked ➜ Locked	Locked	Jun 24 2025
Chardan Capital	Locked ➜ Locked	Locked	Apr 01 2025
TD Cowen	Locked ➜ Locked	Locked	Jan 21 2025
Chardan Capital	Locked ➜ Locked	Locked	Dec 04 2024
Chardan Capital	Locked ➜ Locked	Locked	Nov 15 2024
Chardan Capital	Locked ➜ Locked	Locked	Aug 19 2024

Analyst Rating	Date
Locked Chardan Capital: Locked ➜ Locked	Jun 24 2025
Locked Chardan Capital: Locked ➜ Locked	Apr 01 2025
Locked TD Cowen: Locked ➜ Locked	Jan 21 2025
Locked Chardan Capital: Locked ➜ Locked	Dec 04 2024
Locked Chardan Capital: Locked ➜ Locked	Nov 15 2024
Locked Chardan Capital: Locked ➜ Locked	Aug 19 2024

Discover more stocks with a high price target

Berkshire Hathaway 154,261.00%

Alibaba Group Holding Ltd 1,077.45%

BioNTech SE - ADR 31.42%

Tencent Holdings Ltd. 26.26%

Adyen 24.86%

Deutsche Telekom 24.51%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now